MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,773.95
+0.66%
NASDAQ 100
$31,076.44
+0.87%
DOW JONES
$51,268.00
+0.18%
NASDAQ Composite
$27,477.31
+1.05%
RUSSELL 2000
$2,833.80
+0.66%
CBOE VIX
$15.52
+1.37%
Sector Heatmap
Technology+0.53%
Financials+0.24%
Healthcare-0.17%
Consumer Cycl+1.20%
Consumer Staples+0.90%
Energy+0.47%
Industrials+0.87%
Materials+0.46%
Real Estate+1.06%
Utilities+2.98%
Comm Services+0.04%
LSTA — Lisata Therapeutics, Inc. Common Stock
NasdaqLisata Therapeutics, Inc. Common Stock
$1.21
-0.05(-3.97%)
- O
- 1.31
- H
- 1.32
- L
- 1.14
- V
- 124K
⏱️ End-of-day dataAs of Oct 6, 2026
LSTA — Latest News & Headlines
6 StoriesLisata Therapeutics, Inc. (LSTA) Stock Price, News, Quote & History - Yahoo! Finance Canada
Lisata Therapeutics, Inc. (LSTA) Stock Price, News, Quote & History Yahoo! Finance Canada
A rare hormone disorder trial doses its first patient; its drug may allow shots every two weeks, not daily. - Stock Titan
A rare hormone disorder trial doses its first patient; its drug may allow shots every two weeks, not daily. Stock Titan
With $0 left to sell, Lisata Therapeutics (LSTA) reports an exempt offering. - Stock Titan
With $0 left to sell, Lisata Therapeutics (LSTA) reports an exempt offering. Stock Titan
EQUITY ALERT - The M&A Class Action Firm Launches Inquiry -- LSTA, FSHP, BWIN, and ACVA - PR Newswire
EQUITY ALERT - The M&A Class Action Firm Launches Inquiry -- LSTA, FSHP, BWIN, and ACVA PR Newswire
Halper Sadeh LLC is Investigating Whether BWIN, LSTA, ACVA are Obtaining Fair Deals for their Shareholders - The Daily Tribune News
Halper Sadeh LLC is Investigating Whether BWIN, LSTA, ACVA are Obtaining Fair Deals for their Shareholders The Daily Tribune News
Lisata Therapeutics (LSTA) Buys Marea and Signs $225M Financing. Is the Dilution Worth it? - Insider Monkey
Lisata Therapeutics (LSTA) Buys Marea and Signs $225M Financing. Is the Dilution Worth it? Insider Monkey